E171 is a food additive that manufacturers use to whiten various products, including chewing gum, cake icing, and candy, for instance.
While the addition of this substance may render certain products more appealing, there is an ongoing debate about its safety.
France, for instance, will ban the use of E171 in food products starting next year, over concerns that the additive could lead to health problems.
4D Pharma plc (LON:DDDD) is a world leader in the development of live biotherapeutics, a novel and emerging class of drugs, defined by the FDA as biological products that contain a live organism, such as a bacteria, that is applicable to the prevention, treatment or cure of a disease.